Activating natural cytotoxicity receptors of natural killer cells in cancer and infection.
about
Viral Evasion of Natural Killer Cell ActivationUnderground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsNatural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor ActivityNK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinomaModulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complexSelective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptorHNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins.Decreased NK cell functions in obesity can be reactivated by fat mass reduction.Altered expression of miR-181a and miR-146a does not change the expression of surface NCRs in human NK cells.Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control.Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.NKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization.A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cellsControl of acute dengue virus infection by natural killer cells.Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor ImmunityNK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cellsBinding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study.An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities.Stromal-dependent tumor promotion by MIF family members.Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor SurveillanceTargeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes.Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1Tumor-Associated Glycans and Immune SurveillanceInterferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.HSV1 MicroRNA Modulation of GPI Anchoring and Downstream Immune Evasion.Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.Differential loss of natural killer cell activity in patients with acute myocardial infarction and stable angina pectorisThe RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB.Accumulation of Intrahepatic TNF-α-Producing NKp44+ NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV InfectionThe human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity.Natural killer cells: multifaceted players with key roles in hepatitis C immunity.Found: a cellular activating ligand for NKp44.Human decidual NK cells: unique and tightly regulated effector functions in healthy and pathogen-infected pregnancies.Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer.Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells.Escape from IFN-γ-dependent immunosurveillance in tumorigenesis.
P2860
Q26748421-356F076F-F23E-435A-A57E-F219F0DFA50CQ26751011-66D35A8A-B18A-4BA9-80DC-749EAFC270A0Q26773135-DE9984DD-FF65-4890-B000-7FC4B8ADA5CAQ27001052-ED26B5D4-FB96-450B-AFF2-8EF30252CCEDQ27001661-4496EAB5-0527-4FC0-8335-0580EE225965Q27318470-338FA914-C773-41F0-960B-D04C33595E8DQ30314863-0DBB2356-C0DB-47AD-B583-E5C15DF22426Q30316117-B24201DF-3686-490F-AABD-181BE398194FQ30364263-4C17D89B-1C9C-4520-8C83-9893123E21D8Q30413217-B443AA86-E635-482D-98B7-A6E5E3AA8966Q30648415-FB02C47C-988B-4B98-AD2D-F6483BA13E81Q30665729-D8E649A5-F269-4463-BF2F-D408C3040F51Q33292224-5D1425E0-61E4-413B-AE9C-EE482E158119Q33633893-B1EDA68D-6D4F-4E97-8B89-2A3764F5CC71Q33700795-2D30D25B-560D-4DA0-AB72-9BBC039E0EF9Q33798745-EB3C2F10-EF9B-44BF-9557-5E6C6E72CC49Q34011491-90A16718-7950-4CE7-93AA-637987AF2659Q34043164-218CBDB9-6EDC-4354-8CA8-4258C19F212BQ34625817-E5098A2E-3FA0-496D-8555-BD4666585CDEQ34786615-1FBCF8EA-C854-4C22-9A48-784F4F56BA49Q34944820-2C3968EB-4FE4-47D3-B1F4-EB461DF18327Q35040765-1CB43ACE-4233-4D54-AD20-3C66215E3ADCQ35086418-3E00FA38-4E81-4D1B-AE13-0DA9D235E525Q35125149-AC54AF2B-88AC-4E0C-BFBC-0C7C4007B9B6Q35556765-1C20EABB-6975-4B9F-9D6D-C39737730C02Q35624098-B7A6ABCA-3FA5-4B14-9660-135C97CDC7C1Q35890610-04964D35-AE56-463E-8021-A7B1F522E958Q36093940-54D99A9E-3AC6-431C-8621-A04DF58926DDQ36168132-19247669-6AA3-4AFB-BC3E-A92DA29893EDQ36318152-36BBDEEC-D771-4B17-A59E-D141F33E19ECQ36464559-58E33636-8BB3-48E1-B6DC-3B6B451B06D9Q36723387-CC2F8938-9856-4C8C-BE87-19C666BC783DQ36993610-8D472124-8DBA-4AC7-A766-EEB70F79ABA6Q37022389-14DE0441-24D8-49C7-A02F-BBF658E183EAQ37151472-48B95020-21C7-454D-809D-AB0083913A99Q37263136-AC7CF55B-D8CC-489A-8261-8C6103D05611Q37338982-D596B25D-B1F1-446B-A3A6-C48DB3421A3FQ37370451-44AED80F-8F4D-46FC-A2BF-F347DDE79763Q37405517-E42D34D0-EF8C-4551-8AE8-7A2F87EB94EAQ37618482-DE5A7374-05AE-484F-B452-5BB12D36BF5D
P2860
Activating natural cytotoxicity receptors of natural killer cells in cancer and infection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Activating natural cytotoxicit ...... cells in cancer and infection.
@en
type
label
Activating natural cytotoxicit ...... cells in cancer and infection.
@en
prefLabel
Activating natural cytotoxicit ...... cells in cancer and infection.
@en
P356
P1433
P1476
Activating natural cytotoxicit ...... cells in cancer and infection.
@en
P2093
Joachim Koch
Ofer Mandelboim
P304
P356
10.1016/J.IT.2013.01.003
P577
2013-02-13T00:00:00Z